Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY 303366

Known as: LY-303366, LY303366 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

anidulafungin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Echinocandins: a new class of antifungal.
  • D. Denning
  • The Journal of antimicrobial chemotherapy
  • 2002
    • Corpus ID: 7562690
1103, p. 371. American Society for Microbiology, Washington, DC. 5. Villanueva, A., Arathoon, E. G., Gotuzzo, E., Berman, R. S… Expand
Highly Cited
2000
Highly Cited
2000
Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans andCryptococcus neoformans
ABSTRACT The postantifungal effect (PAFE) of fluconazole, MK-0991, LY303366, and amphotericin B was determined against isolates… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1998
Highly Cited
1998
Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts
ABSTRACT The in vitro antifungal activities of SCH56592, MK-0991, and LY303366 against 83 isolates of Acremonium strictum… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
1998
Highly Cited
1998
In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
LY303366 and MK-0991 (previously L-743,792) are new echinocandin derivatives with excellent broad-spectrum antifungal activity… Expand
Highly Cited
1998
Highly Cited
1998
Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods
ABSTRACT This study was designed to examine the effects of antifungal carryover, agitation, and starting inoculum on the results… Expand
Highly Cited
1998
Highly Cited
1998
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
MK-0991 (formerly L-743,872) is a water soluble semisynthetic echinocandin that possess potent, broad-spectrum antifungal… Expand
Highly Cited
1998
Highly Cited
1998
Efficacy of LY303366 against Amphotericin B-Susceptible and -Resistant Aspergillus fumigatus in a Murine Model of Invasive Aspergillosis
ABSTRACT LY303366 is a novel antifungal echinocandin with excellent in vitro activity against Aspergillus spp. We compared four… Expand
Highly Cited
1997
Highly Cited
1997
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.
LY303366 is a new semisynthetic echinocandin derivative with potent, broad-spectrum fungicidal activity. We investigated the in… Expand
Review
1994
Review
1994
Antibiotics that inhibit fungal cell wall development.
The discovery of antifungal agents that possess selective toxicity against the eukaryotic fungal cell remains an important… Expand
Highly Cited
1994
Highly Cited
1994
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.
The lipopeptide antifungal agents, echinocandins, papulacandins, and pneumocandins, kill Candida albicans by inhibiting glucan… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE